Showing 11,281 - 11,300 results of 103,572 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (nn decrease)) ))', query time: 1.59s Refine Results
  1. 11281

    Characteristics of treatment modality. by Adekunle Emmanuel Sajo (15285520)

    Published 2025
    “…The median time to completion of radiotherapy treatment was higher among those who received primary radiotherapy as compared to those who received adjuvant treatment, 51.5 vs 46 days, p 0.039. The annual average age decreased from 56 years to as low as 40 years, a mean difference of 16 years, p 0.012.…”
  2. 11282

    Demographic and clinical characteristics. by Adekunle Emmanuel Sajo (15285520)

    Published 2025
    “…The median time to completion of radiotherapy treatment was higher among those who received primary radiotherapy as compared to those who received adjuvant treatment, 51.5 vs 46 days, p 0.039. The annual average age decreased from 56 years to as low as 40 years, a mean difference of 16 years, p 0.012.…”
  3. 11283
  4. 11284
  5. 11285

    Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse Prostate by Melissa Gamat (802437)

    Published 2015
    “…Other genes implicated in prostatic development including <i>Sox9</i>, <i>Wif1</i> and <i>Srd5a2</i> were unaffected by DFMO. Together these results indicate that <i>Odc1</i> and polyamines are required for androgens to exert their effect in mediating prostatic bud induction, and are required for the expression of a subset of prostatic developmental regulatory genes including <i>Notch1</i> and <i>Nkx3</i>.…”
  6. 11286

    Data_Sheet_1_Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence.pdf by Lavanya Visvabharathy (797665)

    Published 2022
    “…The patient was prescribed nirmatrelvir/ritonavir to treat SARS-CoV-2 persistence at 3.5 months post-acute infection and observed a reduction in PASC symptoms 3 weeks after completing antiviral treatment. …”
  7. 11287

    Vanadium Oxides on Aluminum Oxide Supports. 3. Metastable κ-Al<sub>2</sub>O<sub>3</sub>(001) Compared to α-Al<sub>2</sub>O<sub>3</sub>(0001) by Tanya K. Todorova (2026051)

    Published 2007
    “…As the length of the polymeric species increases, the reduction energy decreases. We demonstrate that the support structure does affect the structure of the model catalyst and the lattice oxygen bond strength. …”
  8. 11288
  9. 11289

    Table 1_Biomarkers for SARS-CoV-2 infection. A narrative review.docx by Sara Weronika Snopkowska Lesniak (20936051)

    Published 2025
    “…To this end, we performed a revision of studies that investigated laboratory abnormalities in patients with COVID-19, comparing non-severe and severe patients. …”
  10. 11290
  11. 11291
  12. 11292

    AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance by Irene Benito-Cuesta (5280182)

    Published 2020
    “…Inhibition of AMPK with compound C generated the expected decrease in autophagy induction, though surprisingly did not increase the Aβ secretion. …”
  13. 11293
  14. 11294
  15. 11295
  16. 11296
  17. 11297
  18. 11298

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”
  19. 11299
  20. 11300